Şunu aradınız:: sorivudine (Maltaca - İngilizce)

sorivudine u analogi
sorivudine and analogues

ċerti mediċini antivirali (sorivudine u brivudine)
certain anti-viral medicines (sorivudine and brivudine)

antivirali bħal brivudine jew sorivudine impedituri tal-enzima cyp2a6 li tattiva teysuno bħal tranylcypromine u methoxsalen
antivirals such as brivudine or sorivudine inhibitors of the enzyme cyp2a6 which activates teysuno such as tranylcypromine and methoxsalen

- jekk qed tiġi kkurat issa jew kont ikkurat fl- aħħar 4 ġimgħat b’ brivudine, sorivudine jew
- if you are being treated now or have been treated in the last 4 weeks with brivudine, sorivudine

kura fi żmien 4 ġimgħat b'impedituri ta' dpd, li jinkludu sorivudine jew l-analogi kimikament relatati bħal brivudine.
treatment within 4 weeks with dpd inhibitors, including sorivudine or its chemically related analogues such as brivudine.

teysuno m'għandux jintuża ma' sorivudine jew brivudine jew fi żmien 4 ġimgħat mill-aħħar doża ta' sorivudine jew brivudine.
teysuno must not be used with sorivudine or brivudine or within 4 weeks of the last dose of sorivudine or brivudine.

giet deskritta interazzjoni ta’ sinifikanza klinika bejn sorivudine u 5-fu, li rriżultat mill-impedizzjoni ta’ dihydropyrimidine dehydrogenase minn sorivudine.
a clinically significant interaction between sorivudine and 5-fu, resulting from the inhibition of dihydropyrimidine dehydrogenase by sorivudine, has been described.

sorivudine u analogi: ġiet deskritta interazzjoni ta’ sinifikanza klinika bejn sorivudine u 5-fu, li rriżultat mill-impedizzjoni ta’ dihydropyrimidine dehydrogenase minn sorivudine.
sorivudine and analogues: a clinically significant drug-drug interaction between sorivudine and 5-fu, resulting from the inhibition of dihydropyrimidine dehydrogenase by sorivudine, has been described.